"KCAA has been serving the community since 1979. We’re proud to be Kansas City’s premier caregivers and researchers for allergy, asthma, and immunologic diseases. All of our doctors are board-certified by the American Board of Allergy and Immunology. They’ve received advanced training. It’s this training that helps pinpoint specific health issues – and determine the most effective treatment."

During the past decade, Kansas City Allergy and Asthma conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City Allergy and Asthma" #1 sponsor was "Meda Pharmaceuticals" with 7 trials, followed by "Cumberland Pharmaceuticals" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Accentia Biopharmaceuticals" with 1 trials sponsored and "Allergy Therapeutics" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Allergy and Asthma" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Tanox" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City Allergy and Asthma" are "Seasonal Allergic Rhinitis" (5 trials), "Asthma" (3 trials), "Hereditary Angioedema (HAE)" (2 trials), "Perennial Allergic Rhinitis" (2 trials) and "Allergic Reactions" (1 trials). Many other conditions were trialed in "Kansas City Allergy and Asthma" in a lesser frequency.

Most popular intervention types in "Kansas City Allergy and Asthma" are "Drug" (15 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "fluticasone propionate" (3 trials), "0.15% azelastine hydrochloride" (2 trials), "azelastine Hcl" (2 trials) and "ecallantide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Allergy and Asthma" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kansas City Allergy and Asthma". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Kansas City Allergy and Asthma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Allergy and Asthma, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".